Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011616
Filing Date
2024-08-08
Accepted
2024-08-08 16:23:41
Documents
62
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gpcr-20240630x10q.htm   iXBRL 10-Q 2502714
2 EX-31.1 gpcr-20240630xex31d1.htm EX-31.1 16246
3 EX-31.2 gpcr-20240630xex31d2.htm EX-31.2 16902
4 EX-32.1 gpcr-20240630xex32d1.htm EX-32.1 9945
5 EX-32.2 gpcr-20240630xex32d2.htm EX-32.2 10232
6 GRAPHIC gpcr-20240630x10q001.jpg GRAPHIC 59983
  Complete submission text file 0001558370-24-011616.txt   8713768

Data Files

Seq Description Document Type Size
7 EX-101.SCH gpcr-20240630.xsd EX-101.SCH 47698
8 EX-101.CAL gpcr-20240630_cal.xml EX-101.CAL 46774
9 EX-101.DEF gpcr-20240630_def.xml EX-101.DEF 201326
10 EX-101.LAB gpcr-20240630_lab.xml EX-101.LAB 458752
11 EX-101.PRE gpcr-20240630_pre.xml EX-101.PRE 345321
65 EXTRACTED XBRL INSTANCE DOCUMENT gpcr-20240630x10q_htm.xml XML 1413193
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41608 | Film No.: 241188789
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)